Johnson & Johnson to Invest More Than $2 Billion in New, Advanced Technology Manufacturing Facility in North Carolina to Support Robust Portfolio Growth
October 02, 2024
October 02, 2024
NEW BRUNSWICK, New Jersey, Oct. 2 -- Johnson and Johnson issued the following news release:
Oct. 1, 2024 - Johnson & Johnson (NYSE: JNJ) today announced an investment of more than $2 billion to build a state-of-the-art biologics manufacturing facility in Wilson, North Carolina. The new facility will expand production of the Company's portfolio and pipeline of innovative biologics in support of Johnson & Johnson's broader plan to advance more than 70 novel therapy and product . . .
Oct. 1, 2024 - Johnson & Johnson (NYSE: JNJ) today announced an investment of more than $2 billion to build a state-of-the-art biologics manufacturing facility in Wilson, North Carolina. The new facility will expand production of the Company's portfolio and pipeline of innovative biologics in support of Johnson & Johnson's broader plan to advance more than 70 novel therapy and product . . .